SCHEMBL6353196

SCHEMBL6353196

CCCCN(CC#N)S(=O)(=O)c1ccc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALB P02768 2/20 0.53
ALDH1A1 P00352 2/20 0.52
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
P4HB P07237 2/20 0.47
CA12 O43570 4/20 0.45
CA9 Q16790 4/20 0.45
CA1 P00915 2/20 0.44
PLK1 P53350 6/20 0.44
PLK3 Q9H4B4 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
APEX1 P27695 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352671 0.93 SMN1; SMN2 (0.58) ALBALDH1A1LMNASMN1; SMN2P4HB
SCHEMBL6359345 0.91 ALB (0.53) ALBALDH1A1LMNASMN1; SMN2P4HB
SCHEMBL6357082 0.90 APEX1 (0.56) ALBALDH1A1LMNASMN1; SMN2P4HB
SCHEMBL6359077 0.83 ALB (0.56) ALBALDH1A1LMNASMN1; SMN2CA12
SCHEMBL6352948 0.83 APEX1 (0.63) ALBALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL6353693 0.82 ALB (0.55) ALBALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL6835831 0.81 ALB (0.38) ALBALDH1A1LMNASMN1; SMN2P4HB
SCHEMBL6353472 0.81 APEX1 (0.56) ALBALDH1A1LMNASMN1; SMN2P4HB
SCHEMBL6352988 0.80 TAS2R14 (0.56) ALBALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL6352320 0.79 TAS2R14 (0.57) ALBALDH1A1LMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 ALB 1682/4885ALDH1A1 462/4885LMNA 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.